Primary Sjögren's Syndrome Adversely Affects the Female Sexual Function Assessed by the Female Sexual Function Index: A Case-Control Study

Overview

Journal Arch Rheumatol

Specialty Rheumatology

Date 2018 Oct 31

PMID 30375566

Citations 3

Authors

Caglar Yildiz

Savas Karakus

Ozlem Bozoklu Akkar

Ali Sahin

Birkan Bozkurt

Ali Yanik

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aims to evaluate the sexual function of females with primary Sjögren's syndrome (pSS) in comparison to healthy females by using the Female Sexual Function Index (FSFI).

Patients And Methods: This case-control study included 31 female patients (mean age 46.0±10.2 years; range 30 to 68 years) with pSS and 27 healthy females (mean age 44.2±8.5 years; range 30 to 55 years) as control group. The sexual function of the participants was assessed by 19-item FSFI.

Results: Mean duration of pSS in the patient group was 35.9 months (range 3 to 264 months). Significantly higher number of pSS patients reported positive history for vaginal infection compared to controls (n=26, 83.9% vs. n=7, 25.9%, respectively; p<0.001) without any difference in endocervical culture result. Cervical smear assessment revealed more inflammation and atrophy in patient group compared to control group (p=0.001). Mean FSFI total score was significantly lower in patient group than control group (18.9±9.9 vs. 25.1±5.1, respectively; p=0.004). Similarly, five out of six domains of FSFI -arousal, lubrication, orgasm, satisfaction, and pain- were significantly lower in patient group. FSFI total and subscale scores, except for pain, were found to be negatively correlated with duration of pSS.

Conclusion: The pSS causes sexual dysfunction in female patients. Furthermore, as disease duration increases, female sexual function decreases. Clinical management of female patients with pSS should cover the assessment of their sexual functionality and taking the necessary precautions to maintain satisfactory quality of life and treatment outcome.

Citing Articles

Impact of Sjögren's disease on quality of sexual life using the Qualisex score.

Kachaner A, Seror R, Le Guern V, Dieude P, Gottenberg J, Hachulla E RMD Open. 2025; 11(1).

PMID: 39842871 PMC: 11784214. DOI: 10.1136/rmdopen-2024-004693.

Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Pastoor H, Mousa A, Bolt H, Bramer W, Burgert T, Dokras A Hum Reprod Update. 2024; 30(3):323-340.

PMID: 38237144 PMC: 11063549. DOI: 10.1093/humupd/dmad034.

LAMP3 inhibits autophagy and contributes to cell death by lysosomal membrane permeabilization.

Tanaka T, Warner B, Michael D, Nakamura H, Odani T, Yin H Autophagy. 2021; 18(7):1629-1647.

PMID: 34802379 PMC: 9298453. DOI: 10.1080/15548627.2021.1995150.

The impact of Sjӧgren's syndrome on the quality of sexual life of female patients in the UK: a controlled analysis.

Al-Ezzi M, Tappuni A, Khan K Rheumatol Int. 2021; 42(8):1423-1429.

PMID: 33688999 PMC: 9287246. DOI: 10.1007/s00296-021-04830-6.

References

Lehrer S, Bogursky E, Yemini M, Kase N, Birkenfeld A . Gynecologic manifestations of Sjögren's syndrome. Am J Obstet Gynecol. 1994; 170(3):835-7. DOI: 10.1016/s0002-9378(94)70294-2. View

Schoofs N . Caring for women living with Sjögren's syndrome. J Obstet Gynecol Neonatal Nurs. 2003; 32(5):589-93. DOI: 10.1177/0884217503257142. View

Reksten T, Jonsson M . Sjögren's syndrome: an update on epidemiology and current insights on pathophysiology. Oral Maxillofac Surg Clin North Am. 2013; 26(1):1-12. DOI: 10.1016/j.coms.2013.09.002. View

Skopouli F, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos H . Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. Ann Rheum Dis. 1994; 53(9):569-73. PMC: 1005407. DOI: 10.1136/ard.53.9.569. View

Araujo D, Borba E, Abdo C, Souza L, Goldenstein-Schainberg C, Chahade W . [Sexual function in rheumatic diseases]. Acta Reumatol Port. 2010; 35(1):16-23. View

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H, Alexander E, Carsons S . Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61(6):554-8. PMC: 1754137. DOI: 10.1136/ard.61.6.554. View

Mavragani C, Fragoulis G, Moutsopoulos H . Endocrine alterations in primary Sjogren's syndrome: an overview. J Autoimmun. 2012; 39(4):354-8. DOI: 10.1016/j.jaut.2012.05.011. View

Brandt J, Priori R, Valesini G, Fairweather D . Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ. 2015; 6:19. PMC: 4630965. DOI: 10.1186/s13293-015-0037-7. View

Maddali Bongi S, Rosso A, Orlandi M, Matucci-Cerinic M . Gynaecological symptoms and sexual disability in women with primary Sjögren's syndrome and sicca syndrome. Clin Exp Rheumatol. 2013; 31(5):683-90. View

10.

Luciano N, Valentini V, Calabro A, Elefante E, Vitale A, Baldini C . One year in review 2015: Sjögren's syndrome. Clin Exp Rheumatol. 2015; 33(2):259-71. View

11.

Konttinen Y, Porola P, Konttinen L, Laine M, Poduval P . Immunohistopathology of Sjögren's syndrome. Autoimmun Rev. 2006; 6(1):16-20. DOI: 10.1016/j.autrev.2006.03.003. View

12.

Tristano A . The impact of rheumatic diseases on sexual function. Rheumatol Int. 2009; 29(8):853-60. DOI: 10.1007/s00296-009-0850-6. View

13.

Maslinska M, Przygodzka M, Kwiatkowska B, Sikorska-Siudek K . Sjögren's syndrome: still not fully understood disease. Rheumatol Int. 2014; 35(2):233-41. PMC: 4308635. DOI: 10.1007/s00296-014-3072-5. View

14.

Cirpan T, Guliyeva A, Onder G, Terek M, Ozsaran A, Kabasakal Y . Comparison of human papillomavirus testing and cervical cytology with colposcopic examination and biopsy in cervical cancer screening in a cohort of patients with Sjogren's syndrome. Eur J Gynaecol Oncol. 2007; 28(4):302-6. View

15.

van Nimwegen J, Arends S, van Zuiden G, Vissink A, Kroese F, Bootsma H . The impact of primary Sjögren's syndrome on female sexual function. Rheumatology (Oxford). 2015; 54(7):1286-93. DOI: 10.1093/rheumatology/keu522. View

16.

Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Durusoy R, Mete N . The prevalence of Sjögren's syndrome in adult women. Scand J Rheumatol. 2006; 35(5):379-83. DOI: 10.1080/03009740600759704. View

17.

Ruiz Sada P, Isenberg D, Ciurtin C . Biologic treatment in Sjögren's syndrome. Rheumatology (Oxford). 2014; 54(2):219-30. DOI: 10.1093/rheumatology/keu417. View

18.

Birlik M, Akar S, Gurler O, Sari I, Birlik B, Sarioglu S . Prevalence of primary Sjogren's syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract. 2008; 63(6):954-61. DOI: 10.1111/j.1742-1241.2008.01749.x. View

19.

Priori R, Minniti A, Derme M, Antonazzo B, Brancatisano F, Ghirini S . Quality of Sexual Life in Women with Primary Sjögren Syndrome. J Rheumatol. 2015; 42(8):1427-31. DOI: 10.3899/jrheum.141475. View

20.

Cornec D, Jamin C, Pers J . Sjögren's syndrome: where do we stand, and where shall we go?. J Autoimmun. 2014; 51:109-14. DOI: 10.1016/j.jaut.2014.02.006. View